HB4215

Amends the Newborn Metabolic Screening Act to expand newborn screening for genetic, metabolic, and congenital anomalies.

The bill amends the Newborn Metabolic Screening Act to require all newborns be screened for genetic, metabolic, and congenital anomalies, including hearing disorders. It specifies that beginning July 1, 2026, the base fee for newborn screening services shall be $165. The Department of Public Health must allocate 22% of the base fee to the Early Hearing Detection and Intervention Program. The bill also requires the Department to establish quality standards for mammography and provide coverage for certain mammograms and breast cancer treatments.